comparemela.com

Latest Breaking News On - Laboratory head - Page 15 : comparemela.com

Lifetime investigating malaria leads to drugs that push back on resistance… And CSL Florey Medal

Lifetime investigating malaria leads to drugs that push back on resistance… And CSL Florey Medal
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

IonOpticks ushers in a new age of proteomics with Aurora Frontier

MELBOURNE, Australia, Nov. 24, 2022 /PRNewswire/ The field of proteomics is set to be revolutionised with the launch today of IonOpticks' Aurora Frontier that achieves more than 10,000 proteins per sample. This near-full proteome coverage, a depth previously considered unattainable, unlocksthe potential for ground-breaking scientific discoveries in human health. Proteomics provides a greater understanding of the complexity of life than other forms of in-depth biological research approaches, such as genomics, as it provides deeper insight into the structure and function of proteins and how they react within the cell in response to their environment. Director and Head of Research at IonOpticks, and Laboratory Head at Walter and Eliza Hall Institute of Medical Research (WEHI), Associate Professor Andrew Webb, says that proteomics has long been acknowledged as the future of medical research by the scientific community. "We've entered the post-genomic era and the scientific c

IAEA - International Atomic Energy Agency - Associate Project Officer (Radioecology Laboratory), Monaco

Brightest cancer researchers WEHI teams awarded new funding grants

Brightest cancer researchers WEHI teams awarded new funding grants
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Brandon Capital Invests in Neuroscience Company NRG Therapeutics

Brandon Capital, Australasia’s leading life science venture capital firm, is pleased to announce its investment into neuroscience company NRG Therapeutics as part of its £16m (AUD$29m) series A financing. Brandon Capital participated alongside Omega Funds, which led the round, as well as NRG’s founding investor .

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.